Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment|[quest]|

I Vandenput; B Van Calster; A Capoen; K Leunen; P Berteloot; P Neven; Ph Moerman; I Vergote; F Amant

首页> 外文期刊>British Journal of Cancer >Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment|[quest]|

【24h】

Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment|[quest]|

机译：经腹膜扩散的浆液性子宫内膜癌患者的新辅助化疗，然后进行间隔减瘤术（Ⅳ期）：一种新的首选治疗方法

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:To investigate the value of neoadjuvant chemotherapy (NACT), followed by interval debulking surgery (IDS), in endometrial cancer with transperitoneal spread (stage IV).

机译：背景：为了研究新辅助化疗（NACT），然后进行间隔减瘤术（IDS），在经腹膜扩散的子宫内膜癌中的价值（IV期）。

著录项

来源
《British Journal of Cancer》 |2009年第2期|共6页
作者
I Vandenput; B Van Calster; A Capoen; K Leunen; P Berteloot; P Neven; Ph Moerman; I Vergote; F Amant;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Patterns of Recurrence and Clinical Outcome of Patients With Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response After Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery An Italian Multicenter Retrospective Study [J] . Gadducci Angiolo, Cosio Stefania, Zizioli Valentina, International journal of gynecological cancer: official journal of the International Gynecological Cancer Society . 2017,第1期

机译：在初级消泡手术加上化疗或Neoadjuvant化疗后，II阶段II阶段阶段IV阶段上皮卵巢癌的患者的复发和临床结果的临床结果
2. Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602 [J] . Onda Takashi, Satoh Toyomi, Saito Toshiaki, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：日本临床肿瘤学小组研究JCOG0602在III期/ IV期卵巢癌，输卵管癌和腹膜癌新辅助化疗后的前期减容手术与间隔减容手术之间的治疗侵袭性比较：
3. Potential risk factors associated with prognosis of neoadjuvant chemotherapy followed by interval debulking surgery in stage IIIc-IV high-grade serous ovarian carcinoma patients [J] . Zhang Jie, Liu Ning, Zhang Aihong, The journal of obstetrics and gynaecology research . 2018,第9期

机译：与新辅助化疗预后相关的潜在风险因素，随后是IIIC-IV高级浆膜癌患者的间隔不稳压手术
4. Breast MRI radiomics for the pre-treatment prediction of response to neoadjuvant chemotherapy in node-positive breast cancer patients [C] . Karen Drukker, Iman El-Bawab, Alexandra Edwards, SPIE Conference on Computer-Aided Diagnosis . 2019

机译：乳腺MRI辐射射清，用于节点阳性乳腺癌患者对新辅助化疗的反应预处理预测
5. Supportive Care for Patients with Breast Cancer by Using an Interactive App During Neoadjuvant Chemotherapy: A Randomized Controlled Trial [D] . Fjell, Maria. 2021

机译：通过在Neoadjuvant化疗期间使用互动性应用的乳腺癌患者的支持性护理：随机对照试验
6. Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment? [O] . I Vandenput, B Van Calster, A Capoen, 2009

机译：在腹膜扩散的浆液性子宫内膜癌患者中进行新辅助化疗然后进行间隔减瘤术（IV期）：一种新的首选治疗方法？
7. Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment? [O] . Vandenput, I, Van Calster, B, Capoen, A, 2009

机译：在腹膜扩散的浆液性子宫内膜癌患者中进行新辅助化疗，然后进行间隔减瘤术（IV期）：一种新的首选治疗方法？

Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment|[quest]|

摘要

著录项

相似文献

相关主题

期刊订阅